SOX10 and central nervous system cancer: Kaplan‐‐Meier survival analysis showed that a higher circEPHB4 or SOX10 level was independently correlated with reduced overall survival, whereas a higher miR‐637 was independently correlated with enhanced overall survival of glioma patients (Fig. 1D).